Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a69681008a628a443257b49621b2e506 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-397 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-397 |
filingDate |
2018-06-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2023-01-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c5afdea3e7bd5b0987f2e21c88b078cd http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cd2ca7a43c09e21560b4c080748fe907 |
publicationDate |
2023-01-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-11541033-B2 |
titleOfInvention |
Agent for preventing or treating Alzheimer's disease |
abstract |
An object of the present invention is to provide a drug which prevents progress of Alzheimer's disease and a method of preventing progress of Alzheimer's disease. Alzheimer's disease can be effectively prevented or treated by initiating administration of a pharmaceutical composition comprising 1-(3-(2-(1-benzothiophen-5-yl)ethoxy)propyl)azetidin-3-ol or a salt thereof as an active ingredient to a patient within a certain period from clinical diagnosis of Alzheimer's disease. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11660287-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11666551-B2 |
priorityDate |
2017-06-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |